{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:07:31Z","timestamp":1772136451548,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UKRI, MRC","award":["MR\/S031812\/1"],"award-info":[{"award-number":["MR\/S031812\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The toxicity of purine bases adenine and guanine is mostly recognized when associated with inborn errors of purine metabolism such as Lesch-Nyhan syndrome, and metabolic diseases with a lifestyle component including gout. In these pathologies, the peripheral toxicity of purine bases is attributed to the accumulation of their catabolite uric acid in the kidneys, causing nephrolithiasis or crystalluria, and the joints, causing gout. However, inborn errors of purine metabolism also present neurological and neurobehavioral abnormalities including motor disabilities, seizures, hypotonia and dystonia, and self-injurious behaviour. The mechanisms underlying these pathologies is less well-understood but does not seem to be caused by uric acid. In a different context, adenine and guanine have been shown to be cytotoxic and antiproliferative, highlighting their potential use in cancer chemotherapies, but the underlying mechanisms have not been identified. In our previous investigations, we have shown that adenine, a molecule classified as acutely toxic, is an inhibitor of 1-carbon metabolism and biological methylations. Using the same experimental paradigm based on real-time luminometry with mouse embryonic fibroblasts to probe in real-time the potential biological activity of small molecules, complemented with metabolite quantifications, in silico docking predictions, kinase assays and phosphoproteomics, we now reveal that guanine and to a lesser extent adenine are direct inhibitors of c-Jun N-terminal kinases, which may contribute to their toxicity and to the symptoms of Lesch-Nyhan syndrome.<\/jats:p>","DOI":"10.1038\/s41598-025-11617-3","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:35:59Z","timestamp":1754919359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guanine is an inhibitor of c-jun terminal kinases"],"prefix":"10.1038","volume":"15","author":[{"given":"Jessica","family":"Treeby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherihan","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Maddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Warwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Selley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Saer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Fustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"11617_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini, S. & Pedata, F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463\u2013484. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00607.x (2001).","journal-title":"J. Neurochem"},{"key":"11617_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.14336\/AD.2016.0208","volume":"7","author":"D Lanznaster","year":"2016","unstructured":"Lanznaster, D., Dal-Cim, T., Piermartiri, T. C. & Tasca, C. I. Guanosine: a neuromodulator with therapeutic potential in brain disorders. Aging Dis. 7, 657\u2013679. https:\/\/doi.org\/10.14336\/AD.2016.0208 (2016).","journal-title":"Aging Dis."},{"key":"11617_CR3","doi-asserted-by":"publisher","unstructured":"Torres, R. J. & Puig, J. G. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J. Rare Dis. 2 https:\/\/doi.org\/10.1186\/1750-1172-2-48 (2007).","DOI":"10.1186\/1750-1172-2-48"},{"key":"11617_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/B978-0-444-59565-2.00052-6","volume":"113","author":"HA Jinnah","year":"2013","unstructured":"Jinnah, H. A., Sabina, R. L. & Van Den Berghe, G. Metabolic disorders of purine metabolism affecting the nervous system. Handb. Clin. Neurol. 113, 1827\u20131836. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00052-6 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"11617_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archinte.1972.03650020016004","volume":"130","author":"WL Nyhan","year":"1972","unstructured":"Nyhan, W. L. Clinical features of the Lesch-Nyhan syndrome. Arch. Intern. Med. 130, 186\u2013192 (1972).","journal-title":"Arch. Intern. Med."},{"key":"11617_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/nen.0b013e3180515319","volume":"66","author":"MR Del Bigio","year":"2007","unstructured":"Del Bigio, M. R. & Halliday, W. C. Multifocal atrophy of cerebellar internal granular neurons in lesch-nyhan disease: case reports and review. J. Neuropathol. Exp. Neurol. 66, 346\u2013353. https:\/\/doi.org\/10.1097\/nen.0b013e3180515319 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"11617_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/brain\/awl056","volume":"129","author":"HA Jinnah","year":"2006","unstructured":"Jinnah, H. A. et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 129, 1201\u20131217. https:\/\/doi.org\/10.1093\/brain\/awl056 (2006).","journal-title":"Brain"},{"key":"11617_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0165-0173(99)00094-6","volume":"32","author":"JE Visser","year":"2000","unstructured":"Visser, J. E., Bar, P. R. & Jinnah, H. A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Brain Res. Rev. 32, 449\u2013475. https:\/\/doi.org\/10.1016\/s0165-0173(99)00094-6 (2000).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"11617_CR9","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.bbi.2009.07.006","volume":"23","author":"MG Garcia","year":"2009","unstructured":"Garcia, M. G., Puig, J. G. & Torres, R. J. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients. Brain Behav. Immun. 23, 1125\u20131131. https:\/\/doi.org\/10.1016\/j.bbi.2009.07.006 (2009).","journal-title":"Brain Behav. Immun."},{"key":"11617_CR10","first-page":"2357","volume":"38","author":"FF Snyder","year":"1978","unstructured":"Snyder, F. F., Hershfield, M. S. & Seegmiller, J. E. Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts. Cancer Res. 38, 2357\u20132362 (1978).","journal-title":"Cancer Res."},{"key":"11617_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1126\/science.197600","volume":"197","author":"MS Hershfield","year":"1977","unstructured":"Hershfield, M. S., Snyder, F. F. & Seegmiller, J. E. Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Sci. (New York N Y). 197, 1284\u20131287. https:\/\/doi.org\/10.1126\/science.197600 (1977). [doi].","journal-title":"Sci. (New York N Y)"},{"key":"11617_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-3002(61)90846-0","volume":"47","author":"L Aronow","year":"1961","unstructured":"Aronow, L. Reversal of adenine toxicity by pyrimidine mucleosides. Biochim. Biophys. Acta. 47, 184\u2013185 (1961). doi:0006-3002(61)90846-0 [pii].","journal-title":"Biochim. Biophys. Acta"},{"key":"11617_CR13","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1039\/c4sc03949a","volume":"6","author":"N Zhang","year":"2015","unstructured":"Zhang, N. et al. Cytotoxicity of guanine-based degradation products contributes to the antiproliferative activity of guanine-rich oligonucleotides. Chem. Sci. 6, 3831\u20133838. https:\/\/doi.org\/10.1039\/c4sc03949a (2015).","journal-title":"Chem. Sci."},{"key":"11617_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymgme.2014.11.001","volume":"114","author":"R Fu","year":"2015","unstructured":"Fu, R. et al. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways. Mol. Genet. Metab. 114, 55\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2014.11.001 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"11617_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1471-4159.2007.04472.x","volume":"101","author":"TL Shirley","year":"2007","unstructured":"Shirley, T. L. et al. A human neuronal tissue culture model for Lesch-Nyhan disease. J. Neurochem. 101, 841\u2013853. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04472.x (2007).","journal-title":"J. Neurochem"},{"key":"11617_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s42003-022-03280-5","volume":"5","author":"K Fukumoto","year":"2022","unstructured":"Fukumoto, K. et al. Excess S-adenosylmethionine inhibits methylation via catabolism to adenine. Commun. Biol. 5, 313. https:\/\/doi.org\/10.1038\/s42003-022-03280-5 (2022).","journal-title":"Commun. Biol."},{"key":"11617_CR17","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1073\/pnas.0308709101","volume":"101","author":"SH Yoo","year":"2004","unstructured":"Yoo, S. H. et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U S A. 101, 5339\u20135346. https:\/\/doi.org\/10.1073\/pnas.0308709101 (2004). [doi].","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11617_CR18","doi-asserted-by":"publisher","unstructured":"Greco, C. M. et al. S-adenosyl-l-homocysteine hydrolase links methionine metabolism to the circadian clock and chromatin remodeling. Sci. Adv. 6 https:\/\/doi.org\/10.1126\/sciadv.abc5629 (2020).","DOI":"10.1126\/sciadv.abc5629"},{"key":"11617_CR19","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1073\/pnas.1721371115","volume":"115","author":"JM Fustin","year":"2018","unstructured":"Fustin, J. M. et al. Two Ck1delta transcripts regulated by m6A methylation code for two antagonistic kinases in the control of the circadian clock. Proc. Natl. Acad. Sci. U S A. 115, 5980\u20135985. https:\/\/doi.org\/10.1073\/pnas.1721371115 (2018). [doi].","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11617_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","volume":"155","author":"JM Fustin","year":"2013","unstructured":"Fustin, J. M. et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155, 793\u2013806. https:\/\/doi.org\/10.1016\/j.cell.2013.10.026 (2013). [doi].","journal-title":"Cell"},{"key":"11617_CR21","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/nar\/gkv047","volume":"43","author":"AN Lane","year":"2015","unstructured":"Lane, A. N. & Fan, T. W. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 43, 2466\u20132485. https:\/\/doi.org\/10.1093\/nar\/gkv047 (2015).","journal-title":"Nucleic Acids Res."},{"key":"11617_CR22","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382 (2019).","journal-title":"Nucleic Acids Res."},{"key":"11617_CR23","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","volume":"29","author":"D Gfeller","year":"2013","unstructured":"Gfeller, D., Michielin, O. & Zoete, V. Shaping the interaction landscape of bioactive molecules. Bioinf. (Oxford England). 29, 3073\u20133079. https:\/\/doi.org\/10.1093\/bioinformatics\/btt540 (2013). [doi].","journal-title":"Bioinf. (Oxford England)"},{"key":"11617_CR24","doi-asserted-by":"crossref","unstructured":"Littler, E. & Zhou, X. X. in Comprehensive Medicinal Chemistry II (eds John B. Taylor & David J. Triggle) 295\u2013327Elsevier, (2007).","DOI":"10.1016\/B0-08-045044-X\/00212-1"},{"key":"11617_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0163-7258(00)00097-8","volume":"88","author":"A Bzowska","year":"2000","unstructured":"Bzowska, A., Kulikowska, E. & Shugar, D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Ther. 88, 349\u2013425. https:\/\/doi.org\/10.1016\/s0163-7258(00)00097-8 (2000).","journal-title":"Pharmacol. Ther."},{"key":"11617_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/embor.2012.37","volume":"13","author":"H Yoshitane","year":"2012","unstructured":"Yoshitane, H. et al. JNK regulates the photic response of the mammalian circadian clock. EMBO Rep. 13, 455\u2013461. https:\/\/doi.org\/10.1038\/embor.2012.37 (2012).","journal-title":"EMBO Rep."},{"key":"11617_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/B978-0-12-396456-4.00013-4","volume":"106","author":"K Sabapathy","year":"2012","unstructured":"Sabapathy, K. Role of the JNK pathway in human diseases. Prog Mol. Biol. Transl Sci. 106, 145\u2013169. https:\/\/doi.org\/10.1016\/B978-0-12-396456-4.00013-4 (2012).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"11617_CR28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.csbj.2020.06.013","volume":"18","author":"MTH Duong","year":"2020","unstructured":"Duong, M. T. H., Lee, J. H. & Ahn, H. C. C-Jun N-terminal kinase inhibitors: structural insight into kinase-inhibitor complexes. Comput. Struct. Biotechnol. J. 18, 1440\u20131457. https:\/\/doi.org\/10.1016\/j.csbj.2020.06.013 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"11617_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/jm501212r","volume":"58","author":"P Koch","year":"2015","unstructured":"Koch, P., Gehringer, M. & Laufer, S. A. Inhibitors of c-Jun N-terminal kinases: an update. J. Med. Chem. 58, 72\u201395. https:\/\/doi.org\/10.1021\/jm501212r (2015).","journal-title":"J. Med. Chem."},{"key":"11617_CR30","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1021\/jm060199b","volume":"49","author":"BG Szczepankiewicz","year":"2006","unstructured":"Szczepankiewicz, B. G. et al. Aminopyridine-Based c-Jun N-Terminal kinase inhibitors with cellular activity and minimal Cross-Kinase activity. J. Med. Chem. 49, 3563\u20133580. https:\/\/doi.org\/10.1021\/jm060199b (2006).","journal-title":"J. Med. Chem."},{"key":"11617_CR31","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1021\/acs.jmedchem.2c01834","volume":"66","author":"W Lu","year":"2023","unstructured":"Lu, W. et al. Development of a covalent inhibitor of c-Jun N-Terminal protein kinase (JNK) 2\/3 with selectivity over JNK1. J. Med. Chem. 66, 3356\u20133371. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01834 (2023).","journal-title":"J. Med. Chem."},{"key":"11617_CR32","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1016\/j.bmcl.2009.03.043","volume":"19","author":"J Cao","year":"2009","unstructured":"Cao, J. et al. Structure-based design and parallel synthesis of N-benzyl Isatin oximes as JNK3 MAP kinase inhibitors. Bioorg. Med. Chem. Lett. 19, 2891\u20132895 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"11617_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/cb1002619","volume":"6","author":"KM Comess","year":"2011","unstructured":"Comess, K. M. et al. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. ACS Chem. Biol. 6, 234\u2013244 (2011).","journal-title":"ACS Chem. Biol."},{"key":"11617_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20070797","volume":"408","author":"J Bain","year":"2007","unstructured":"Bain, J. et al. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297\u2013315. https:\/\/doi.org\/10.1042\/BJ20070797 (2007).","journal-title":"Biochem. J."},{"key":"11617_CR35","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1073\/pnas.251194298","volume":"98","author":"BL Bennett","year":"2001","unstructured":"Bennett, B. L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U S A. 98, 13681\u201313686. https:\/\/doi.org\/10.1073\/pnas.251194298 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11617_CR36","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553. https:\/\/doi.org\/10.1093\/nar\/gkae1011 (2025).","journal-title":"Nucleic Acids Res."},{"key":"11617_CR37","doi-asserted-by":"publisher","first-page":"e3000170","DOI":"10.1371\/journal.pbio.3000170","volume":"17","author":"K Engholm-Keller","year":"2019","unstructured":"Engholm-Keller, K. et al. The Temporal profile of activity-dependent presynaptic phospho-signalling reveals long-lasting patterns of poststimulus regulation. PLoS Biol. 17, e3000170. https:\/\/doi.org\/10.1371\/journal.pbio.3000170 (2019).","journal-title":"PLoS Biol."},{"key":"11617_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.molcel.2004.08.028","volume":"15","author":"K Sabapathy","year":"2004","unstructured":"Sabapathy, K. et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell. 15, 713\u2013725. https:\/\/doi.org\/10.1016\/j.molcel.2004.08.028 (2004).","journal-title":"Mol. Cell."},{"key":"11617_CR39","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molcel.2006.07.028","volume":"23","author":"A Jaeschke","year":"2006","unstructured":"Jaeschke, A. et al. JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell. 23, 899\u2013911. https:\/\/doi.org\/10.1016\/j.molcel.2006.07.028 (2006).","journal-title":"Mol. Cell."},{"key":"11617_CR40","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1128\/MCB.01362-12","volume":"33","author":"V Gandin","year":"2013","unstructured":"Gandin, V. et al. Degradation of newly synthesized polypeptides by ribosome-associated RACK1\/c-Jun N-terminal kinase\/eukaryotic elongation factor 1A2 complex. Mol. Cell. Biol. 33, 2510\u20132526. https:\/\/doi.org\/10.1128\/MCB.01362-12 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"11617_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ymgme.2015.02.007","volume":"114","author":"EB Dammer","year":"2015","unstructured":"Dammer, E. B. et al. Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease. Mol. Genet. Metab. 114, 570\u2013579. https:\/\/doi.org\/10.1016\/j.ymgme.2015.02.007 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"11617_CR42","doi-asserted-by":"publisher","first-page":"100213","DOI":"10.1016\/j.patter.2021.100213","volume":"2","author":"DJB Clarke","year":"2021","unstructured":"Clarke, D. J. B. et al. Appyters: turning Jupyter notebooks into data-driven web apps. Patterns (N Y). 2, 100213. https:\/\/doi.org\/10.1016\/j.patter.2021.100213 (2021).","journal-title":"Patterns (N Y)"},{"key":"11617_CR43","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.chembiol.2005.04.011","volume":"12","author":"ZA Knight","year":"2005","unstructured":"Knight, Z. A. & Shokat, K. M. Features of selective kinase inhibitors. Chem. Biol. 12, 621\u2013637. https:\/\/doi.org\/10.1016\/j.chembiol.2005.04.011 (2005).","journal-title":"Chem. Biol."},{"key":"11617_CR44","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.stemcr.2021.06.003","volume":"16","author":"S Bell","year":"2021","unstructured":"Bell, S. et al. Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells. Stem Cell. Rep. 16, 1749\u20131762. https:\/\/doi.org\/10.1016\/j.stemcr.2021.06.003 (2021).","journal-title":"Stem Cell. Rep."},{"key":"11617_CR45","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1021\/acs.jproteome.1c00143","volume":"20","author":"A Palomba","year":"2021","unstructured":"Palomba, A. et al. Comparative evaluation of MaxQuant and proteome discoverer MS1-Based protein quantification tools. J. Proteome Res. 20, 3497\u20133507. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00143 (2021).","journal-title":"J. Proteome Res."},{"key":"11617_CR46","doi-asserted-by":"publisher","first-page":"103669","DOI":"10.1016\/j.jprot.2020.103669","volume":"215","author":"L Zhao","year":"2020","unstructured":"Zhao, L. et al. Comparative evaluation of label-free quantification strategies. J. Proteom. 215, 103669. https:\/\/doi.org\/10.1016\/j.jprot.2020.103669 (2020).","journal-title":"J. Proteom."},{"key":"11617_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11926-011-0231-5","volume":"14","author":"RJ Torres","year":"2012","unstructured":"Torres, R. J., Puig, J. G. & Jinnah, H. A. Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr. Rheumatol. Rep. 14, 189\u2013194. https:\/\/doi.org\/10.1007\/s11926-011-0231-5 (2012).","journal-title":"Curr. Rheumatol. Rep."},{"key":"11617_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s1570-0232(03)00277-0","volume":"792","author":"C Ohdoi","year":"2003","unstructured":"Ohdoi, C., Nyhan, W. L. & Kuhara, T. Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 792, 123\u2013130. https:\/\/doi.org\/10.1016\/s1570-0232(03)00277-0 (2003).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"11617_CR49","doi-asserted-by":"crossref","unstructured":"Nyhan, W. L. in In Neurocutaneous Disorders. 186\u2013199 (eds Steve, E., Roach, Van, S. & Miller) (Cambridge University Press, 2004).","DOI":"10.1017\/CBO9780511545054.026"},{"key":"11617_CR50","doi-asserted-by":"publisher","first-page":"eadd7046","DOI":"10.1126\/science.add7046","volume":"382","author":"K Siletti","year":"2023","unstructured":"Siletti, K. et al. Transcriptomic diversity of cell types across the adult human brain. Science 382, eadd7046. https:\/\/doi.org\/10.1126\/science.add7046 (2023).","journal-title":"Science"},{"key":"11617_CR51","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/MCB.01864-08","volume":"29","author":"H Yoshitane","year":"2009","unstructured":"Yoshitane, H. et al. Roles of CLOCK phosphorylation in suppression of E-box-dependent transcription. Mol. Cell. Biol. 29, 3675\u20133686. https:\/\/doi.org\/10.1128\/MCB.01864-08 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"11617_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1074\/jbc.M107850200","volume":"277","author":"K Sanada","year":"2002","unstructured":"Sanada, K., Okano, T. & Fukada, Y. Mitogen-activated protein kinase phosphorylates and negatively regulates basic helix-loop-helix-PAS transcription factor BMAL1. J. Biol. Chem. 277, 267\u2013271. https:\/\/doi.org\/10.1074\/jbc.M107850200 (2002).","journal-title":"J. Biol. Chem."},{"key":"11617_CR53","doi-asserted-by":"publisher","first-page":"32207","DOI":"10.1074\/jbc.M606357200","volume":"281","author":"M Suter","year":"2006","unstructured":"Suter, M. et al. Dissecting the role of 5\u2019-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281, 32207\u201332216. https:\/\/doi.org\/10.1074\/jbc.M606357200 (2006).","journal-title":"J. Biol. Chem."},{"key":"11617_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(94)01006-4","volume":"353","author":"JE Sullivan","year":"1994","unstructured":"Sullivan, J. E. et al. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353, 33\u201336. https:\/\/doi.org\/10.1016\/0014-5793(94)01006-4 (1994).","journal-title":"FEBS Lett."},{"key":"11617_CR55","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.108.784298","volume":"118","author":"E Schulz","year":"2008","unstructured":"Schulz, E. et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 118, 1347\u20131357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.784298 (2008).","journal-title":"Circulation"},{"key":"11617_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.1172156","volume":"326","author":"KA Lamia","year":"2009","unstructured":"Lamia, K. A. et al. AMPK regulates the circadian clock by Cryptochrome phosphorylation and degradation. Science 326, 437\u2013440. https:\/\/doi.org\/10.1126\/science.1172156 (2009).","journal-title":"Science"},{"key":"11617_CR57","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.122016499","volume":"99","author":"E Bender","year":"2002","unstructured":"Bender, E. et al. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc. Natl. Acad. Sci. U S A. 99, 8573\u20138578. https:\/\/doi.org\/10.1073\/pnas.122016499 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11617_CR58","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/sj.bjp.0704542","volume":"135","author":"U Traversa","year":"2002","unstructured":"Traversa, U. et al. Specific [(3)H]-guanosine binding sites in rat brain membranes. Br. J. Pharmacol. 135, 969\u2013976. https:\/\/doi.org\/10.1038\/sj.bjp.0704542 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"11617_CR59","doi-asserted-by":"publisher","first-page":"e96462","DOI":"10.1371\/journal.pone.0096462","volume":"9","author":"T Zielinski","year":"2014","unstructured":"Zielinski, T., Moore, A. M., Troup, E., Halliday, K. J. & Millar, A. J. Strengths and limitations of period Estimation methods for circadian data. PloS One. 9, e96462. https:\/\/doi.org\/10.1371\/journal.pone.0096462 (2014). [doi].","journal-title":"PloS One"},{"key":"11617_CR60","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.1021\/ac5025842","volume":"86","author":"CJ Tape","year":"2014","unstructured":"Tape, C. J. et al. Reproducible automated phosphopeptide enrichment using magnetic TiO2 and Ti-IMAC. Anal. Chem. 86, 10296\u201310302. https:\/\/doi.org\/10.1021\/ac5025842 (2014).","journal-title":"Anal. Chem."},{"key":"11617_CR61","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372. https:\/\/doi.org\/10.1038\/nbt.1511 (2008).","journal-title":"Nat. Biotechnol."},{"key":"11617_CR62","doi-asserted-by":"publisher","unstructured":"Hong, Y. et al. PhosPiR: an automated phosphoproteomic pipeline in R. Brief. Bioinform. 23 https:\/\/doi.org\/10.1093\/bib\/bbab510 (2022).","DOI":"10.1093\/bib\/bbab510"},{"key":"11617_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67\u201373. https:\/\/doi.org\/10.1177\/108705719900400206 (1999).","journal-title":"J. Biomol. Screen."},{"key":"11617_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1087057105285610","volume":"11","author":"PW Iversen","year":"2006","unstructured":"Iversen, P. W., Eastwood, B. J., Sittampalam, G. S. & Cox, K. L. A comparison of assay performance measures in screening assays: signal window, Z\u2019 factor, and assay variability ratio. J. Biomol. Screen. 11, 247\u2013252. https:\/\/doi.org\/10.1177\/1087057105285610 (2006).","journal-title":"J. Biomol. Screen."},{"key":"11617_CR65","unstructured":"Inc, C. C. G. (Chemical Computing Group Inc. 1010 Sherbooke St. West, Suite# 910, Montreal &#8230."},{"key":"11617_CR66","unstructured":"OpenEye, S. & Software https:\/\/www.eyesopen.com"},{"key":"11617_CR67","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PC Hawkins","year":"2010","unstructured":"Hawkins, P. C., Skillman, A. G., Warren, G. L., Ellingson, B. A. & Stahl, M. T. Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database. J. Chem. Inf. Model. 50, 572\u2013584 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"11617_CR68","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1021\/ci100436p","volume":"51","author":"MFRED McGann","year":"2011","unstructured":"McGann, M. F. R. E. D. Pose prediction and virtual screening accuracy. J. Chem. Inf. Model. 51, 578\u2013596. https:\/\/doi.org\/10.1021\/ci100436p (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"11617_CR69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","volume":"26","author":"M McGann","year":"2012","unstructured":"McGann, M. FRED and HYBRID Docking performance on standardized datasets. J. Comput. Aided Mol. Des. 26, 897\u2013906. https:\/\/doi.org\/10.1007\/s10822-012-9584-8 (2012).","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11617-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11617-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11617-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:14:56Z","timestamp":1757373296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11617-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11617"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11617-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6521885\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"29374"}}